Time-Limited Trials and Potentially Nonbeneficial Treatment in the ICU-Willing to Wait for It

Richard E Leiter^{1

2

3}, James A Tulsky^{1

2

3}

Affiliations

¹ Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

Comment

Richard E Leiter et al. JAMA Intern Med. 2021.

. 2021 Jun 1;181(6):795-796.

doi: 10.1001/jamainternmed.2021.0988.

Richard E Leiter^{1

2

3}, James A Tulsky^{1

2

3}

¹ Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments.
Chang DW, Neville TH, Parrish J, Ewing L, Rico C, Jara L, Sim D, Tseng CH, van Zyl C, Storms AD, Kamangar N, Liebler JM, Lee MM, Yee HF Jr. Chang DW, et al. JAMA Intern Med. 2021 Jun 1;181(6):786-794. doi: 10.1001/jamainternmed.2021.1000. JAMA Intern Med. 2021. PMID: 33843946 Free PMC article.